Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
gabapentin + tramadol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pain
1 trial -
ginkgolide
The First People's Hospital of Lianyungang
Intravenous Alteplase Thrombolysis
1 trial -
glargine + exenatide
Hong Kong Baptist University
Type 2 Diabetes Mellitus
1 trial -
glatiramer acetate injection with oral cetirizine hydrochloride
Teva Pharma GmbH
Multiple Sclerosis
1 trial -
handwashing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Communicable Diseases
1 trial -
hepatitis B vaccine made by Recombinant DNA Techniques in Saccharomyces Cerevisiae
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis B Vaccines
1 trial -
hyaluronic Acid + platelet-rich plasma
Regeneron Ireland Designated Activity Company (DAC)
Knee Osteoarthritis
1 trial -
hyaluronidase (human recombinant)/rehydration fluid
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
hydrochloride hydromorphone + flurbiprofen axetil
The First People's Hospital of Lianyungang
Enhanced Recovery After Surgery
1 trial -
hydroxyethl starch
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cesarean Section
1 trial -
hylenex-facilitated subcutaneous Lactated Ringer's infusion
HALOZYME THERAPEUTICS, INC.
Dehydration
1 trial -
iloperidone
Vanda Pharmaceuticals Netherlands B.V.
Bipolar Disorder
1 trial -
insulin detemir
Novo Nordisk A/S
Diabetes
2 trials -
insulin lispro injection, exenatide injection
The First People's Hospital of Lianyungang
Diabetes Mellitus, Type 2
1 trial -
intravenous sufentanil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Analgesia, Patient-Controlled
1 trial -
isoniazid, rifampin, pyrazinamide
Hospital Authority, Hong Kong
Hepatitis
1 trial -
lactate group:lactate acide clearance directed group; ScvO2 group:ScvO2 directed group;control group
Chinese University of Hong Kong
Shock, Septic
1 trial -
lamivudine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Compensated Chronic Hepatitis B
1 trial -
low-dose rivaroxaban
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Atrial Fibrillation
1 trial -
low-dose tenecteplase intravenous thrombolysis
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke Patients
1 trial -
medication for opioid use disorder
BRIGHT MINDS BIOSCIENCES INC.
Opioid Use Disorder
1 trial -
melphalan hydrochloride for injection
CASI Pharmaceuticals
Multiple Myeloma
2 trials -
mesenchymal stromal cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
MSC
1 trial -
methadone
BRIGHT MINDS BIOSCIENCES INC.
Heroin Dependence
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources